|Articles|January 5, 2009

HBA - Laurie P. Cook endorsement letter

HBA Endorsement letter

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe

Related Content

Pharmaceutical Executive Daily: Meaningfully Improving Therapy Persistence in Patient Support Programs

ByNicholas Jacobus

June 17th 2026

Private equity and other forms of private capital have played a critical role in funding healthcare innovations. Credit: Stock.Adobe.com/putilov_denis

Private Equity in Healthcare After Connecticut: Why the Life Sciences Industry Needs Stewardship Capital, Not Financial Engineering

ByThani Jambulingam, PhD

June 17th 2026

FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report

ByNicholas Jacobus

June 17th 2026

Pharma M&A Roundup: Protillion Biosciences Enters Drug Discovery Collaboration with Merck, Jazz Pharmaceuticals and AbCellera Enter Collaboration

ByNicholas Jacobus

June 17th 2026

Brian Hilberdink, president of U.S. Human Pharma, Boehringer Ingelheim,

Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?

ByNicholas Jacobus,Brian Hilberdink

June 17th 2026

HBA - Laurie P. Cook endorsement letter

Related Content

Pharmaceutical Executive Daily: Meaningfully Improving Therapy Persistence in Patient Support Programs

Private Equity in Healthcare After Connecticut: Why the Life Sciences Industry Needs Stewardship Capital, Not Financial Engineering

FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report

Pharma M&A Roundup: Protillion Biosciences Enters Drug Discovery Collaboration with Merck, Jazz Pharmaceuticals and AbCellera Enter Collaboration

Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?

Trending on PharmExec

Where Does Boehringer Ingelheim Stand Between Oral or Injectable GLP-1’s Being The Future of Obesity Care?

How Behavioral and Engagement Insights Improve Persistence in Patient Support Programs

FDA Files Concerns Over Missing Data for Moderna’s mRNA Flu Shot: Report

Elicio Therapeutics’ Shares Drop Following Announcement of Phase II Trial Results

The Industry's Interest in Vaccine Platforms